Skip to main content
Erschienen in: Medical Oncology 1/2012

01.03.2012 | Original Paper

Altered mRNA expressions of sialyltransferases in human gastric cancer tissues

verfasst von: Li Jun, Wang Yuanshu, Xie Yanying, Xu Zhongfa, Yang Jian, Wang Fengling, Qu Xianjun, Norihiro Kokudo, Tang Wei, Zhong Weixia, Cui Shuxiang

Erschienen in: Medical Oncology | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Aberrant sialylation and altered sialyltransferase (ST) expressions are frequently found in many types of cancer. In this study, we examined the expressions of α 2,3-linked sialic acid residues and STs mRNA in human gastric cancer tissues. The relationship between the levels of α 2,3-linked sialic acid residues and the expression of STs mRNA was also analyzed. Maackia amurensis leukoagglutinin (MAL) specific for α 2,3-linked sialic acid was used for immunohistochemical staining. All gastric cancer tissues were positive for MAL staining, whereas adjacent normal tissues were negative. The extent of MAL staining was significantly correlated with the behavior of gastric cancer. The expression of STs mRNA was examined by real-time quantitative reverse transcription-polymerase chain reaction assay. The levels of ST3Gal IV and ST6GalI in gastric cancer tissues were significantly increased compared with those in adjacent normal tissues (P < 0.05), whereas the levels of ST3Gal I, ST3Gal III, and ST3Gal VI were not increased. Furthermore, the high expression of ST3Gal IV was closely related to the extent of MAL staining (P < 0.05) unlike that of ST6Gal I. These results indicated that gastric cancer tissues expressed high levels of α 2,3-linked sialic acid residues, ST3Gal IV, and ST6Gal I. The high expression of ST3Gal IV may contribute to the expression of α 2,3-linked sialic acid residues, which is associated with the malignant behavior of gastric cancer cells.
Literatur
1.
Zurück zum Zitat Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T, Tsuruo T, Kannagi R, Miyagi T. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer. 2002;97:180–5.PubMedCrossRef Sawada M, Moriya S, Saito S, Shineha R, Satomi S, Yamori T, Tsuruo T, Kannagi R, Miyagi T. Reduced sialidase expression in highly metastatic variants of mouse colon adenocarcinoma 26 and retardation of their metastatic ability by sialidase overexpression. Int J Cancer. 2002;97:180–5.PubMedCrossRef
2.
Zurück zum Zitat Lin S, Kemmner W, Grigull S, Schlag PM. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 2002;276:101–10.PubMedCrossRef Lin S, Kemmner W, Grigull S, Schlag PM. Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res. 2002;276:101–10.PubMedCrossRef
3.
Zurück zum Zitat Babal P, Janega P, Cerna A, Kholova I, Brabencova E. Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation. Acta Histochem. 2006;108:133–40.PubMedCrossRef Babal P, Janega P, Cerna A, Kholova I, Brabencova E. Neoplastic transformation of the thyroid gland is accompanied by changes in cellular sialylation. Acta Histochem. 2006;108:133–40.PubMedCrossRef
4.
Zurück zum Zitat Wang WC, Cummings RD. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked α-2, 3 to penultimate galactose residues. J Biol Chem. 1988;263:4576–85.PubMed Wang WC, Cummings RD. The immobilized leukoagglutinin from the seeds of Maackia amurensis binds with high affinity to complex-type Asn-linked oligosaccharides containing terminal sialic acid-linked α-2, 3 to penultimate galactose residues. J Biol Chem. 1988;263:4576–85.PubMed
5.
Zurück zum Zitat Tang W, Mafune K, Nakata M, Konishi T, Kojima N, Mizuochi T, Makuuchi M. Association of histochemical expression of Maackia amurensis leukoagglutinin-positive glycoconjugates with behavior of human gastric cancer. Histopathology. 2003;42:239–45.PubMedCrossRef Tang W, Mafune K, Nakata M, Konishi T, Kojima N, Mizuochi T, Makuuchi M. Association of histochemical expression of Maackia amurensis leukoagglutinin-positive glycoconjugates with behavior of human gastric cancer. Histopathology. 2003;42:239–45.PubMedCrossRef
6.
Zurück zum Zitat Wang FL, Cui SX, Sun LP, Qu XJ, Xie YY, Zhou L, Mu YL, Tang W, Wang YS. High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer. Cancer Detect Prev. 2009;32:437–43.PubMedCrossRef Wang FL, Cui SX, Sun LP, Qu XJ, Xie YY, Zhou L, Mu YL, Tang W, Wang YS. High expression of alpha 2, 3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer. Cancer Detect Prev. 2009;32:437–43.PubMedCrossRef
7.
Zurück zum Zitat Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Validation of staging systems for gastric cancer. Gastric Cancer. 2008;11:111–8.PubMedCrossRef Yamashita K, Sakuramoto S, Kikuchi S, Katada N, Kobayashi N, Watanabe M. Validation of staging systems for gastric cancer. Gastric Cancer. 2008;11:111–8.PubMedCrossRef
8.
Zurück zum Zitat Li C, et al. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology. 2009;77(3–4):197–204.PubMedCrossRef Li C, et al. Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer. Oncology. 2009;77(3–4):197–204.PubMedCrossRef
9.
Zurück zum Zitat Czyzewska J, Guzinska-Ustymowicz K, Kemona A, Bandurski R. The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival. Folia Histochem Cytobiol. 2008;46:57–64.PubMedCrossRef Czyzewska J, Guzinska-Ustymowicz K, Kemona A, Bandurski R. The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival. Folia Histochem Cytobiol. 2008;46:57–64.PubMedCrossRef
10.
Zurück zum Zitat Julian J, Carson DD. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem Biophys Res Commun. 2002;293:1183–90.PubMedCrossRef Julian J, Carson DD. Formation of MUC1 metabolic complex is conserved in tumor-derived and normal epithelial cells. Biochem Biophys Res Commun. 2002;293:1183–90.PubMedCrossRef
11.
Zurück zum Zitat Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, Lai CR, Hsieh SL, Yuan CC. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol. 2005;99:631–9.PubMedCrossRef Wang PH, Lee WL, Juang CM, Yang YH, Lo WH, Lai CR, Hsieh SL, Yuan CC. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol. 2005;99:631–9.PubMedCrossRef
12.
Zurück zum Zitat Pengju Z, Weiwen C, Aiying W, Zhaobo C, Nana N, Zhaoqin H, Qingwei L, Anli J. NKX3.1 potentiates TNF-alpha/CHX-induced apoptosis of prostate cancer cells through increasing caspase-3 expression and its activity. Biochem Biophys Res Commun. 2010;398:457–61.PubMedCrossRef Pengju Z, Weiwen C, Aiying W, Zhaobo C, Nana N, Zhaoqin H, Qingwei L, Anli J. NKX3.1 potentiates TNF-alpha/CHX-induced apoptosis of prostate cancer cells through increasing caspase-3 expression and its activity. Biochem Biophys Res Commun. 2010;398:457–61.PubMedCrossRef
13.
Zurück zum Zitat Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J. 1997;14:577–84.PubMedCrossRef Kannagi R. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. Glycoconj J. 1997;14:577–84.PubMedCrossRef
14.
15.
Zurück zum Zitat Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA. 2002;99:10231–3.PubMedCrossRef Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA. 2002;99:10231–3.PubMedCrossRef
16.
Zurück zum Zitat Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology. 2004;14:671–9.PubMedCrossRef Ohyama C, Hosono M, Nitta K, Oh-eda M, Yoshikawa K, Habuchi T, Arai Y, Fukuda M. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Glycobiology. 2004;14:671–9.PubMedCrossRef
17.
Zurück zum Zitat Kannagi R. Carbohydrate antigen sialyl Lewis a–its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J. 2007;30:189–209.PubMed Kannagi R. Carbohydrate antigen sialyl Lewis a–its pathophysiological significance and induction mechanism in cancer progression. Chang Gung Med J. 2007;30:189–209.PubMed
18.
Zurück zum Zitat Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007;446:1023–9.PubMedCrossRef Varki A. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 2007;446:1023–9.PubMedCrossRef
19.
Zurück zum Zitat Christie DR, Shaikh FM, Lucas JA IV, Lucas JA III, Bellis SL. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res. 2008;1:3.PubMedCrossRef Christie DR, Shaikh FM, Lucas JA IV, Lucas JA III, Bellis SL. ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function. J Ovarian Res. 2008;1:3.PubMedCrossRef
20.
Zurück zum Zitat Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005;65:4645–52.PubMedCrossRef Seales EC, Jurado GA, Brunson BA, Wakefield JK, Frost AR, Bellis SL. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility. Cancer Res. 2005;65:4645–52.PubMedCrossRef
21.
Zurück zum Zitat Jain RK, Piskorz CF, Huang BG, Locke RD, Han HL, Koenig A, Varki A, Matta KL. Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acalpha2-3Galbeta1-3GalNAc sequences. Glycobiology. 1998;8:707–17.PubMedCrossRef Jain RK, Piskorz CF, Huang BG, Locke RD, Han HL, Koenig A, Varki A, Matta KL. Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Acalpha2-3Galbeta1-3GalNAc sequences. Glycobiology. 1998;8:707–17.PubMedCrossRef
22.
Zurück zum Zitat Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2004;95:377–84.PubMedCrossRef Kannagi R, Izawa M, Koike T, Miyazaki K, Kimura N. Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 2004;95:377–84.PubMedCrossRef
23.
Zurück zum Zitat Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993;53:354–61.PubMed Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res. 1993;53:354–61.PubMed
24.
Zurück zum Zitat Lopez-Morales D, Velazquez-Marquez N, Valenzuela O, Santos-Lopez G, Reyes-Leyva J, Vallejo-Ruiz V. Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest Clin. 2009;50:45–53.PubMed Lopez-Morales D, Velazquez-Marquez N, Valenzuela O, Santos-Lopez G, Reyes-Leyva J, Vallejo-Ruiz V. Enhanced sialyltransferases transcription in cervical intraepithelial neoplasia. Invest Clin. 2009;50:45–53.PubMed
25.
Zurück zum Zitat Damiani R, Oliveira JE, Vorauer-Uhl K, Peroni CN, Vianna EG, Bartolini P, Ribela MT. Stable expression of a human-like sialylated recombinant thyrotropin in a Chinese hamster ovary cell line expressing alpha 2,6-sialyltransferase. Protein Expr Purif. 2009;67:7–14.PubMedCrossRef Damiani R, Oliveira JE, Vorauer-Uhl K, Peroni CN, Vianna EG, Bartolini P, Ribela MT. Stable expression of a human-like sialylated recombinant thyrotropin in a Chinese hamster ovary cell line expressing alpha 2,6-sialyltransferase. Protein Expr Purif. 2009;67:7–14.PubMedCrossRef
26.
Zurück zum Zitat Taniguchi A. Promoter structure and transcriptional regulation of human beta-galactoside alpha 2, 3-sialyltransferase genes. Curr Drug Targets. 2008;9:310–6.PubMedCrossRef Taniguchi A. Promoter structure and transcriptional regulation of human beta-galactoside alpha 2, 3-sialyltransferase genes. Curr Drug Targets. 2008;9:310–6.PubMedCrossRef
27.
Zurück zum Zitat Petretti T, Schulze B, Schlag PM, Kemmner W. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta. 1999;1428:209–18.PubMedCrossRef Petretti T, Schulze B, Schlag PM, Kemmner W. Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta. 1999;1428:209–18.PubMedCrossRef
28.
Zurück zum Zitat Petretti T, Kemmner W, Schulze B, Schlag PM. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut. 2000;46:359–66.PubMedCrossRef Petretti T, Kemmner W, Schulze B, Schlag PM. Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut. 2000;46:359–66.PubMedCrossRef
Metadaten
Titel
Altered mRNA expressions of sialyltransferases in human gastric cancer tissues
verfasst von
Li Jun
Wang Yuanshu
Xie Yanying
Xu Zhongfa
Yang Jian
Wang Fengling
Qu Xianjun
Norihiro Kokudo
Tang Wei
Zhong Weixia
Cui Shuxiang
Publikationsdatum
01.03.2012
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 1/2012
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9771-1

Weitere Artikel der Ausgabe 1/2012

Medical Oncology 1/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.